ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Acute mental status change in a patient with SLE: Rapid overview

Acute mental status change in a patient with SLE: Rapid overview
Clinical features
  • Acute mental status change may take the form of decreased level of consciousness, delirium or acute confusional state, or acute psychosis
Differential diagnosis – Causes include those that are SLE related and those that are not
  • SLE-related considerations:
    • SLE CNS neuroinflammatory process (sometimes referred to as "lupus psychosis")
    • Stroke (including APS, TTP)
    • Seizure
    • Systemic or CNS infection
    • Medication toxicity (especially glucocorticoid toxicity)
    • Hypertensive encephalopathy
    • RPLS (PRES)
    • Macrophage activation syndrome
    • Electrolyte abnormalities, especially with renal disease
  • Non-SLE-related considerations:
    • Metabolic derangements
    • Drugs, medications, toxins
    • Infection
    • Trauma/exposure
    • Stroke
    • Seizure
    • Primary psychiatric disorders
    • Systemic organ failure
    • Other
Evaluation
  • Comprehensive history and physical examination
  • Laboratory studies:
    • Electrolytes
    • BUN/creatinine
    • Liver function tests
    • CBC with differential
    • TSH
    • Ammonia
    • Urinalysis
    • Toxicology as indicated
    • Cultures as indicated
  • Neuroimaging: Head CT urgently; in follow-up, MRI of the brain with and without gadolinium
  • Lumbar puncture and CSF examination:
    • Opening pressure
    • Cell count with differential
    • Total protein
    • Glucose (with corresponding serum glucose for comparison)
    • IgG index/oligoclonal bands (requires serum sample)
    • Culture
    • Additional infectious diagnostics as clinically indicated
    • Neuronal autoantibodies as clinically indicated
  • EEG
Diagnosis of SLE-associated neuroinflammatory process (lupus psychosis)
  • The attribution of an acute altered mental status to an SLE-associated neuroinflammatory process requires that other causes are excluded with the above evaluation.
  • Evidence of concomitant SLE disease activity supports neuroinflammatory etiology.*
Management
  • Urgent treatment of infection, seizure, metabolic derangement, drug toxicity, stroke, etc, if present.
  • For patients with high level of suspicion of lupus psychosis: Treat with pulse glucocorticoids and/or other immunosuppressive therapy.
  • Antipsychotic drugs as needed for severe symptoms.
SLE: systemic lupus erythematosus; CNS: central nervous system; APS: antiphospholipid antibody syndrome; TTP: thrombotic thrombocytopenia purpura; RPLS: reversible posterior leukoencephalopathy syndrome; PRES: posterior reversible encephalopathy syndrome; BUN: blood urea nitrogen; CBC: complete blood count; TSH: thyroid-stimulating hormone; CT: computed tomography; MRI: magnetic resonance imaging; CSF: cerebrospinal fluid; IgG: immunoglobulin G; EEG: electroencephalography.
* Please refer to UpToDate content on neuropsychiatric manifestations of SLE.
Graphic 131126 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟